Tony Michael Argenbright

Array ( [id] => 5081601 [patent_doc_number] => 20070124825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Use of hepcidin as a regulator of iron homeostasis' [patent_app_type] => utility [patent_app_number] => 11/602402 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8324 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20070124825.pdf [firstpage_image] =>[orig_patent_app_number] => 11602402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904001 [patent_doc_number] => 20080113414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Solid or semi-solid state fermentation of xanthan on potato or potato waste' [patent_app_type] => utility [patent_app_number] => 11/598907 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4440 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113414.pdf [firstpage_image] =>[orig_patent_app_number] => 11598907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 567517 [patent_doc_number] => 07465784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Antimicrobial peptides and methods of identifying the same' [patent_app_type] => utility [patent_app_number] => 11/586943 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20785 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465784.pdf [firstpage_image] =>[orig_patent_app_number] => 11586943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12523992 [patent_doc_number] => 10004828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => Self-assembled Fmoc-ff hydrogels [patent_app_type] => utility [patent_app_number] => 12/083222 [patent_app_country] => US [patent_app_date] => 2006-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 15990 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12083222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555091 [patent_doc_number] => 08066991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Enzyme inhibitors of PAI-1' [patent_app_type] => utility [patent_app_number] => 11/545015 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6580 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/066/08066991.pdf [firstpage_image] =>[orig_patent_app_number] => 11545015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521653 [patent_doc_number] => 09605039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Protein scaffolds for antibody mimics and other binding proteins' [patent_app_type] => utility [patent_app_number] => 11/543316 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 31 [patent_no_of_words] => 20755 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11543316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242845 [patent_doc_number] => 20070021340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Use of blood coagulation factor XIII for treating hemophilia A' [patent_app_type] => utility [patent_app_number] => 11/524021 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2371 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021340.pdf [firstpage_image] =>[orig_patent_app_number] => 11524021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922511 [patent_doc_number] => 20080070827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'METHODS FOR USING SOY PEPTIDES TO INHIBIT H3 ACETYLATION, REDUCE EXPRESSION OF HMG COA REDUCTASE, AND INCREASE LDL RECEPTOR AND SP1 EXPRESSION IN A MAMMAL' [patent_app_type] => utility [patent_app_number] => 11/532528 [patent_app_country] => US [patent_app_date] => 2006-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4353 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070827.pdf [firstpage_image] =>[orig_patent_app_number] => 11532528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995077 [patent_doc_number] => 20070010422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 11/531602 [patent_app_country] => US [patent_app_date] => 2006-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10801 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010422.pdf [firstpage_image] =>[orig_patent_app_number] => 11531602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740553 [patent_doc_number] => 20080234206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Prodrugs of Phentermine' [patent_app_type] => utility [patent_app_number] => 12/065639 [patent_app_country] => US [patent_app_date] => 2006-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7558 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234206.pdf [firstpage_image] =>[orig_patent_app_number] => 12065639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688945 [patent_doc_number] => 20070105753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'USE OF DIPYRIDAMOLE OR MOPIDAMOLE FOR TREATMENT AND PREVENTION OF THROMBO-EMBOLIC DISEASES AND DISORDERS CAUSED BY EXCESSIVE FORMATION OF THROMBIN AND/OR BY ELEVATED EXPRESSION OF THROMBIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/469503 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5121 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105753.pdf [firstpage_image] =>[orig_patent_app_number] => 11469503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875816 [patent_doc_number] => 08470782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Transglutaminase inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/064800 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 17218 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12064800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183489 [patent_doc_number] => 20070054843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Methods for treatment of headaches by administration of oxytocin' [patent_app_type] => utility [patent_app_number] => 11/511997 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17242 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054843.pdf [firstpage_image] =>[orig_patent_app_number] => 11511997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397314 [patent_doc_number] => 20090317377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Therapy procedure for drug delivery for trigeminal pain' [patent_app_type] => utility [patent_app_number] => 11/990878 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19474 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317377.pdf [firstpage_image] =>[orig_patent_app_number] => 11990878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041128 [patent_doc_number] => 20070093410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Selective inhibition of proteasomes of tuberculosis and other bacteria' [patent_app_type] => utility [patent_app_number] => 11/510125 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14288 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093410.pdf [firstpage_image] =>[orig_patent_app_number] => 11510125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995080 [patent_doc_number] => 20070010425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Pharmaceutical compositions and methods for insulin treatment' [patent_app_type] => utility [patent_app_number] => 11/509417 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4502 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010425.pdf [firstpage_image] =>[orig_patent_app_number] => 11509417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602901 [patent_doc_number] => 20060293246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Methods of modulating beta cell function' [patent_app_type] => utility [patent_app_number] => 11/509963 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22014 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293246.pdf [firstpage_image] =>[orig_patent_app_number] => 11509963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 895339 [patent_doc_number] => 07341991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Inhibitors of amyloid precursor protein processing' [patent_app_type] => utility [patent_app_number] => 11/467123 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 38 [patent_no_of_words] => 16576 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341991.pdf [firstpage_image] =>[orig_patent_app_number] => 11467123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146702 [patent_doc_number] => 08163701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Prodrugs of active agents' [patent_app_type] => utility [patent_app_number] => 11/508042 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 23669 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163701.pdf [firstpage_image] =>[orig_patent_app_number] => 11508042 [rel_patent_id] =>[rel_patent_doc_number] =>)